Trials / Completed
CompletedNCT05446532
Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes
Characteristics of Hepatitis B HBsAg & HBsAc Carriers Simultaneously
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Corporacion Parc Tauli · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
HBV infection is a dynamic process with complex interactions between virus replication and the host's immune response. The appearance of anti-HBs after HBV infection generally indicates recovery and immunity to HBV1 infection. However, there are several published studies that describe the coexistence of the marker of chronic infection (HBsAg +) and the marker of functional cure (HBsAc +). There are contradictory studies on whether the coexistence of HBsAg/HBsAc implies a different clinical course.
Conditions
Timeline
- Start date
- 2022-06-15
- Primary completion
- 2022-10-31
- Completion
- 2022-12-31
- First posted
- 2022-07-06
- Last updated
- 2025-05-31
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05446532. Inclusion in this directory is not an endorsement.